Shuttle Pharmaceuticals
SHPH | NASDAQ
$4.24
-$0.29 (-6.40%)
At close: Nov 16, 2026, 4:00 PM ET
$4.24
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
-6.40%
(1D)No price chart data available for 1D timeframe.
Rating
8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #1020/1021 (Top 100%)
Key Statistics
Market Data
Market Cap $20.2M
1D Range
4.16 4.92
52W Range
2.78 25.00
Valuation (TTM)
PE -0.14
PB 1.05
EV/EBITDA -2.01
Valuation (NTM)
Forward PE N/A
Forward PEG -0.01
Price Target $0.00
Cash Flow
FCF Yield -32.4%
SBC Adj. FCF Yield -34.3%
SBC Impact -5.8%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
N/A
Dil EPS 3Y | 5Y -45.1% |
-57.1%
FCF 3Y | 5Y -8.7% |
-29.6%
Returns
ROA -45.0%
ROE -156.8%
ROIC -57.8%
Financial Health
Net Debt
$104.92K
Current Ratio 0.11
Interest Coverage -227.72
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platfo...
Sector Healthcare
Employees 2
IPO Date Aug 31, 2022
Website www.shuttlepharma.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove SHPH